Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Liapakis

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Molecular Pharmacology|January 7, 2009
Alanine scanning mutagenesis of the second extracellular loop of type 1 corticotropin-releasing factor receptor revealed residues critical for peptide bindingKostas Gkountelias, Theodoros Tselios, Maria Venihaki, et al.
Current Molecular Pharmacology|January 21, 2017
The Multi-faceted Profile of Corticotropin-releasing Factor (CRF) Family of Neuropeptides and of their Receptors on the Paracrine/Local Regulation of the Inflammatory ResponseEirini Dermitzaki, Maria Venihaki, Christos Tsatsanis, et al.
The Journal of Biological Chemistry|January 17, 2012
Mapping structural determinants within third intracellular loop that direct signaling specificity of type 1 corticotropin-releasing hormone receptorAnu Punn, Jing Chen, Maria Delidaki, et al.
Biomedicines|March 28, 2026
Heat Shock Protein 70 Deficient Mice Exhibit Reduced Psoriasis-like Skin InflammationAikaterini Kalantidou, Maria Kostakou, Michail Deiktakis, et al.
Current Molecular Pharmacology|February 4, 2025
Two GnRH-mitoxantrone Conjugates, Con-3 and Con-7, Target Endometrial Cancer CellsChristos Markatos, Georgia Biniari, Vlasios Karageorgos, et al.
European Journal of Medicinal Chemistry|February 5, 2019
Development of bioactive gemcitabine-D-Lys<sup>6</sup>-GnRH prodrugs with linker-controllable drug release rate and enhanced biopharmaceutical profileNisar Sayyad, Eirinaios I Vrettos, Theodoros Karampelas, et al.
Hormones (Athens, Greece)|June 3, 2018
Current understanding of the structure and function of family B GPCRs to design novel drugsVlasios Karageorgos, Maria Venihaki, Stelios Sakellaris, et al.
Hormones (Athens, Greece)|April 14, 2019
Selective antagonism of CRF1 receptor by a substituted pyrimidineStelios Sakellaris, Minos-Timotheos Matsoukas, Vlasios Karageorgos, et al.
Bioorganic & Medicinal Chemistry|August 3, 2016
Exploring new scaffolds for angiotensin II receptor antagonismEftichia Kritsi, Minos-Timotheos Matsoukas, Constantinos Potamitis, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 2, 2021
Design, synthesis, structural optimization, SAR, in silico prediction of physicochemical properties and pharmacological evaluation of novel & potent thiazolo[4,5-d]pyrimidine corticotropin releasing factor (CRF) receptor antagonistsMd Rabiul Islam, Mohamed Teleb, Vlasios Karageorgos, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Molecular Pharmacology|January 7, 2009
Alanine scanning mutagenesis of the second extracellular loop of type 1 corticotropin-releasing factor receptor revealed residues critical for peptide bindingKostas Gkountelias, Theodoros Tselios, Maria Venihaki, et al.
Current Molecular Pharmacology|January 21, 2017
The Multi-faceted Profile of Corticotropin-releasing Factor (CRF) Family of Neuropeptides and of their Receptors on the Paracrine/Local Regulation of the Inflammatory ResponseEirini Dermitzaki, Maria Venihaki, Christos Tsatsanis, et al.
The Journal of Biological Chemistry|January 17, 2012
Mapping structural determinants within third intracellular loop that direct signaling specificity of type 1 corticotropin-releasing hormone receptorAnu Punn, Jing Chen, Maria Delidaki, et al.
Biomedicines|March 28, 2026
Heat Shock Protein 70 Deficient Mice Exhibit Reduced Psoriasis-like Skin InflammationAikaterini Kalantidou, Maria Kostakou, Michail Deiktakis, et al.
Current Molecular Pharmacology|February 4, 2025
Two GnRH-mitoxantrone Conjugates, Con-3 and Con-7, Target Endometrial Cancer CellsChristos Markatos, Georgia Biniari, Vlasios Karageorgos, et al.
European Journal of Medicinal Chemistry|February 5, 2019
Development of bioactive gemcitabine-D-Lys<sup>6</sup>-GnRH prodrugs with linker-controllable drug release rate and enhanced biopharmaceutical profileNisar Sayyad, Eirinaios I Vrettos, Theodoros Karampelas, et al.
Hormones (Athens, Greece)|June 3, 2018
Current understanding of the structure and function of family B GPCRs to design novel drugsVlasios Karageorgos, Maria Venihaki, Stelios Sakellaris, et al.
Hormones (Athens, Greece)|April 14, 2019
Selective antagonism of CRF1 receptor by a substituted pyrimidineStelios Sakellaris, Minos-Timotheos Matsoukas, Vlasios Karageorgos, et al.
Bioorganic & Medicinal Chemistry|August 3, 2016
Exploring new scaffolds for angiotensin II receptor antagonismEftichia Kritsi, Minos-Timotheos Matsoukas, Constantinos Potamitis, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 2, 2021
Design, synthesis, structural optimization, SAR, in silico prediction of physicochemical properties and pharmacological evaluation of novel & potent thiazolo[4,5-d]pyrimidine corticotropin releasing factor (CRF) receptor antagonistsMd Rabiul Islam, Mohamed Teleb, Vlasios Karageorgos, et al.
Pageof 5